Novacyt S.A. (LON:NCYT)


Founded in 2005, Novacyt S.A. is a France-based global specialist diagnostic solution provider, engaged in manufacturing, diagnostic and pathogen testing kits based on molecular and protein testing technologies. Its products have application across Life science, human clinical, food and industrial markets.  The group evolved since the acquisition of Lab 21 in June 2014 and acquired Primer design in 2016. Recently acquired IT-IS International Ltd. the group is a major in cancer and other infectious diseases. It has remarkable sales from diagnostic products used in serology, oncology, LBC, haematology and microbiology testing. The group supports a large global customer base which include hospitals and large corporate.  Since 2017, the group’s shares are traded on the London Stock Exchange as LON: NCYT.

The group operates through four core business divisions: IT-IS International, Primer Design, Microgen Bioproducts, and Lab 21 Healthcare. Acquired in 2020, IT-IS International is engaged in the development and manufacture of molecular diagnostic instruments. It offers products from bespoke system development to off the shelf real-time PCR machine and its unique techniques identifies PCR features such as efficiency to yield accurate, dye response, reproducible results, baseline offset and drift and to recognize potential problem samples. Its products include Genesig q16 and q32 and MyGo PCR Systems.

The Prime Design is engaged in designing, manufacturing, validation and supply of Gold standard real-time PCR kits, reagents and instruments. It offers the best custom qPCR assay development services in the world and launched the first rapid and reliable CE-IVD marked SARS-CoV-2 test kit.  Its products include Genesig, PROmate and SNGsig. Genesig is used for Pathogen detection, veterinary, food and water testing and agricultural testing, and more recently the COVID-19 pandemic. PROmate is used for total workflow solution that is nearer to patients, including of sample preparation, analysis on the genesig® q16 and q32 instruments and qPCR amplification, specifically for the detection of SARS-CoV-2 and SNPsig used to detect SARS-CoV-2 variants of concern under 2 hours and run on central laboratory systems and the genesig q16 and q32 rapid PCR systems.

The Microgen Bioproducts offers a range of diagnostic products in the field of serology, bacteriology, microbiology, virology and haematology. These products help in improving patient health.  Its Food and industrial microbiology products include Biochemical identification kits, Latex Agglutination Kits, Path-Chek Hygiene tests, Pulsifier and Bacterial Typing Antisera and its clinical products include SARS-CoV-2 lgG EIA, Biochemical identification kits, Immunology & Haematology, pregnancy tests , and others. The Lab 21 Healthcare is engaged in the manufacturing and supplying of Biotec and Plasmatec branded products, plus a range of reagents and tests for IVD application and blood grouping. Its offers a wide range of products for Infectious disease, Thyroid Function, Fertility, Serology testing, Blood Grouping, Febrile Antigens and SLE.

The group continues to develop and release new products to support customer testing and provide incremental revenues. Its recently release products include SNPsig portfolio to detect COVID-19 variants, PROmate which is a CE-marked kit to improve workflow efficiency of COVID-19 testing when using its q16/q32 PCR instruments, VersaLab to support private sector testing for infectious diseases and LAMP and Lateral flow tests which is a new form of COVID-19 test, relies on Loop-mediated isothermal amplification (LAMP) technology to detect active infection.

Contact Information

company address Novacyt S.A. 13 avenue Morane Saulnier 78140 France

company phone+33.1.39465104

company website

Similar Companies